We are very delighted about the results, because it's the first time in the world that a company is able to show positive phase-three results combining in a single dose flu and Covid vaccine... You get one dose, one needle, which meant ease and peace of mind for the consumer.
In the continuing Moderna trial, the mRNA-1083 jab produced a higher immune response than the licensed comparator vaccines. It matched or bettered currently approved flu jabs, including high-dose ones designed for older people.
[
Collection
]
[
|
...
]